BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AlleyWatch//Events//EN
BEGIN:VEVENT
UID:legacy-31f19e32a25cc52b0eeb881d@events.alleywatch.com
DTSTAMP:20261114T185707Z
DTSTART:20210819T213000Z
DTEND:20210819T223000Z
SUMMARY:Engagement via Empathy\, the Metaverse\, Chat A/B Testing & Cl
 inical Trials
DESCRIPTION:More engagement through empathy in both chatbots and Digit
 al People today and in a future metaverse. Healthcare\, finance\, and 
 more use cases\n\nAbout this event\n\nResearch has shown us that empat
 hy plays a main driver in how we perceive the customer service experie
 nce. Surprisingly\, customers tend to give higher marks to brands base
 d on emotion over ease and effectiveness of engagement.\n\nAccording t
 o Forrester\, committing to empathy is easy\; expressing it through br
 and and CX is hard. Only 53% of global firms believe that their custom
 er experiences show empathy for the consumer.\n\nBoth our expert speak
 ers will share perspectives on empathy in conversational interfaces.\n
 \nSoul Machines will also share scaling empathy and the visual impact 
 of Digital People along with the concept of the metaverse.\n\nAndrew N
 g's collaboration Woebot will deep dive into healthcare and A/B testin
 g and clinical trials\n\nEvent Schedule (EDT Time Zone):\n\n5:30 PM Ge
 tting settled and Zoom joining\n\n5:35 PM Bots and AI Kickoff - Transl
 ating a human experience to AI\n\n5:45 PM Shantenu Agarwal - Solving r
 eal-world customer experience use cases with empathetic Digital People
 \n\n6:00 PM Jose Lopez - Empathy is possible in chatbots plus running 
 A/B testing and clinical trials with a chatbot\n\n6:15 PM Q&A\n\nTalk 
 1\n\nDigital People can help scale this empathy throughout the custome
 r experience. We will highlight a few examples across various industri
 es where this has helped improve customer experience and talk about wh
 at is next as the concept of the Metaverse continues to grow.\n\nTalk 
 2\n\nWoebot will discuss how they run A/B experiments and implement th
 em to run clinical trials in order to demonstrate efficacy and increas
 e user engagement of a bot designed to treat mental disorders.\n\nMent
 al disorders are a leading cause of disability worldwide and the numbe
 r of patients in mental distress is continuously increasing\, especial
 ly in our current pandemic situation. One of the major problems in men
 tal health care is that there are far more patients in mental distress
  than the availability of mental health professionals to support them.
 \n\nWoebot Health aims to address this caveat and make mental health r
 adically accessible to everyone. For that\, we have created a chatbot 
 that delivers digital therapeutic treatments to fight depression and a
 nxiety. Our bot is able to keep context\, show empathy and even recall
  past conversations. Furthermore\, our recent studies have shown that 
 Woebot is able to connect and bond to the patients as effectively or m
 ore than classical therapists. To investigate the clinical application
 s of Woebot\, we are currently undergoing a pivotal clinical trial to 
 seek FDA approval. Recently\, the FDA recognized our technological adv
 ance and awarded Woebot as a Breakthrough Device.\n\nSpeaker Bios:\n\n
 Shantenu Agarwal\, VP of A.I. & Ecosystems\, Soul Machines\n\nShantenu
  Agarwal is the VP of AI & Ecosystem at Soul Machines. He recently was
  at IBM Watson where he built\, launched\, and grew new products since
  its inception and helped customers learn how A.I. will help their bus
 iness and shape the future relationship with their customers. He has s
 poken about the future benefit of how A.I. will empower humanity at fo
 rums such as the World Economic Forum\, the International Monetary Fun
 d Youth Summit\, and various industry conferences. Shantenu is an arde
 nt supporter of the entrepreneurial community where he volunteers at a
  New York incubator helping nascent companies transition from biotech 
 labs to companies and supports entrepreneurs globally through the Ende
 avor network. Shantenu graduated from the University of Pennsylvania w
 ith a degree in Bioengineering and Entrepreneurship and focus on A.I.\
 n\nJose Lopez\, Sr. Software Engineer\, Woebot Healthcare\n\nDriven by
  his curiosity and passion for technology\, Jose Lopez switched his wo
 rk as Program Manager at Airbus Spain to study Technology Management a
 t Carnegie Mellon University. After graduating\, he started crafting c
 ustomer service bots at Sutherland Labs in San Francisco. He is curren
 tly Senior Engineer at Woebot Healthcare.
LOCATION:Bots and AI NYC\, Online Event\, New York\, NY\, 10001
URL:https://www.meetup.com/Bots-and-Artificial-Intelligence/events/279
 796171/?utm_source=listing&utm_medium=email&utm_content=eacn
END:VEVENT
END:VCALENDAR